Pathobiont-driven antibody sialylation through IL-10 undermines vaccination
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci179563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Chih-Ming Tsai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, University of California, La Jolla, California, USA. Hauptthemen laut MEDLINE: Interleukin-10, Staphylococcus aureus, Antibodies, Bacterial. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH, Novo Nordisk Foundation.
Abstract (Originalsprache)
The pathobiont Staphylococcus aureus (Sa) induces nonprotective antibody imprints that underlie ineffective staphylococcal vaccination. However, the mechanism by which Sa modifies antibody activity is not clear. Herein, we demonstrate that IL-10 is the decisive factor that abrogates antibody protection in mice. Sa-induced B10 cells drive antigen-specific vaccine suppression that affects both recalled and de novo developed B cells. Released IL-10 promotes STAT3 binding upstream of the gene encoding sialyltransferase ST3gal4 and increases its expression by B cells, leading to hyper-α2,3sialylation of antibodies and loss of protective activity. IL-10 enhances α2,3sialylation on cell-wall–associated IsdB, IsdA, and MntC antibodies along with suppression of the respective Sa vaccines. Consistent with mouse findings, human anti-Sa antibodies as well as anti-pseudomonal antibodies from cystic fibrosis subjects (high IL-10) are hypersialylated, compared with anti– Streptococcus pyogenes and pseudomonal antibodies from normal individuals. Overall, we demonstrate a pathobiont-centric mechanism that modulates antibody glycosylation through IL-10, leading to loss of staphylococcal vaccine efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Pediatrics, University of California, La Jolla, California, USA.
- Immunology Center of Georgia and Department of Medicine, Augusta University, Augusta, Georgia, USA.
- Glycobiology Research and Training Center, UCSD, La Jolla, California, USA.
- Department of Bioengineering, University of California, La Jolla, California, USA.
- Division of Gastroenterology, Department of Pediatrics, UCSD, La Jolla, California, USA.
- Division of Gastroenterology, Rady Children's Hospital, San Diego, California, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH, Novo Nordisk Foundation
- national institute of health
Zitieren
APA
Tsai, C. M., Hajam, I. A., Caldera, J. R., Chiang, A. W., Gonzalez, C., Du, X., Choudhruy, B., Li, H., Suzuki, E., Askarian, F., Clark, T., Lin, B., Wierzbicki, I. H., Riestra, A. M., Conrad, D. J., Gonzalez, D. J., Nizet, V., Lewis, N. E., & Liu, G. Y. (2024). Pathobiont-driven antibody sialylation through IL-10 undermines vaccination. Journal of Clinical Investigation. https://doi.org/10.1172/jci179563
Vancouver
Tsai CM, Hajam IA, Caldera JR, Chiang AW, Gonzalez C, Du X, et al. Pathobiont-driven antibody sialylation through IL-10 undermines vaccination. Journal of Clinical Investigation. 2024. doi:10.1172/jci179563
BibTeX
@article{Tsai2024,
author = {Tsai, Chih-Ming and Hajam, Irshad A and Caldera, J R and Chiang, Austin Wt and Gonzalez, Cesia and Du, Xin and Choudhruy, Biswa and Li, Haining and Suzuki, Emi and Askarian, Fatemeh and Clark, Ty'Tianna and Lin, Brian and Wierzbicki, Igor H and Riestra, Angelica M and Conrad, Douglas J and Gonzalez, David J and Nizet, Victor and Lewis, Nathan E and Liu, George Y},
title = {Pathobiont-driven antibody sialylation through IL-10 undermines vaccination},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci179563}
}
EUVIMED